Activation-dependent α5β1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells

Blood

Volumn 87, Issue 6, 1996, Pages 2450-2458

  Lundell, Beverly I ^b   McCarthy, James B ^b   Kovach, Nicholas L ^b   Verfaillie, Catherine M ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; CD34 ANTIGEN; DNA; FIBRONECTIN RECEPTOR; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL ADHESION; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STEM CELL; BIOSYNTHESIS; BLAST CELL CRISIS; CANCER STEM CELL; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; DNA REPLICATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MYELOID LEUKEMIA; PATHOLOGY; PHYSIOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; ANTIGENS, NEOPLASM; BLAST CRISIS; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; DNA REPLICATION; DNA, NEOPLASM; FIBRONECTINS; HLA-DR ANTIGENS; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; NEOPLASM PROTEINS; RECEPTORS, FIBRONECTIN; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0029665151     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.6.2450.bloodjournal8762450     Document Type: Article

References (53)

1. Dexter TM, Moore MAS, Sheridan PAS: Maintenance of hematopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro. J Exp Med 145:1612, 1977
2. Long MW, Briddell R, Walter AW, Bruno E, Hoffman R: Human hematopoeitic stem cell adhesion to cytokines and matrix molecules. J Clin Invest 90:251, 1992
3. Kerst JM, Sanders JB, Slaper-Cortenbach ICM, Doorakkers MC, Hooibrink B, van Oers RHJ, von dem Borne AEG, van der Schoot CE: α4β1 and α5β1 are differentially expressed during myelopoiesis and mediate the adhesion of human CD34+ cells to fibionectin in an activation-dependent way. Blood 81:344, 1993
4. Bhatia R, Wayner EA, McGlave PB, Verfaillie CM: Interferon-α restores adhesion of malignant progenitors in CML by restoring β1 integrin function. J Clin Invest 94:384, 1994
5. Verfaillie CM, McCarthy JB, McGlave PB: Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med 174:693, 1991
6. Pytela R, Pierschbacher MD, Ruoslahti E: Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40:191, 1985
7. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG: Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain [CS-I] in plasma fibronectin. J Cell Biol 109:1321, 1989
8. Teixido J, Hemler ME, Greenberger JS, Anklesaria P: Role of β1 and β2 integrins in the adhesion of human CD34+ stem cells to bone marrow stroma. J Clin Invest 90:358, 1992
9. Verfaillie CM: Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long term in vitro hematopoiesis. Blood 79:2821, 1992
10. Hurley R, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
11. Jacobson BS, Branton D: Plasma membrane: Rapid isolation and exposure of the cytoplasmic surface by use of positively charged beads. Science 195:302, 1977
12. Macieira-Coelho A, Avrameas S: Modulation of cell behavior in vitro by the substratum in fibroblastic and leukemic mouse cell lines. Proc Nat Acad Sci USA 69:2469, 1972
13. Hurley RW, McCarthy JB, Verfaillie CM: Actin polymerization is required for α4β1 integrin dependent inhibition of hematopoietic progenitor proliferation. Blood 84:416a, 1994 (abstr, suppl 1)
14. Kantarjian HM, Deisseroth AD, Kurzrock R, Estrov A, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993
15. Rowley JD: A new consistent chromosome abnormality in chronic myelogenous leukemia. Nature 243:209, 1973
16. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF: Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328:342, 1987
17. Verfaillie CM, McCarthy JB, McGlave PB: Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 90:1232, 1992
18. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci U S A 83:5306, 1986
19. Dowding CR, Gordon MY, Goldman JM: Primitive progenitor cells in the blood of patients with chronic granulocyte leukemia. Int J Cell Cloning 4:331, 1986
20. Kovach NL, Carlos TM, Yee E, Harlan JM: A monoclonal antibody to β1 integrin (CD29) stimulates VLA-dependent adhesion of leukocytes to human umbilical vein endothelial cells and matrix components. J Cell Biol 116:499, 1992
21. Lozzio BB, Lozzio CB: Properties and usefulness of the original K562 human myelogenous leukemia cell line. Leuk Res 3:363, 1979
22. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003, 1992
23. McCarthy JB, Haugen ST, Furcht LT: Human fibronectin contains distinctive adhesion and motility-promoting domains for metastatic melanoma cells. J Cell Biol 102:179, 1986
24. Morgan DML, Larvin VL, Pearson ID: Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells. J Cell Sci 94:553, 1989
25. Wayner EA, Carter WG: Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique α and common β subunits. J Cell Biol 105:1873, 1987
26. Verfaillie CM, Catanzarro P, Lin W-L: MIP-1α combined with IL3 conserves primitive human LTBMC-IC for at least 8 weeks in ex vivo "stroma-non-contact" cultures. J Exp Med 179:643, 1994
27. Verfaillie C, Blakolmer K, McGlave P: Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow storma. J Exp Med 172:509, 1990
28. Boyd CD, Pierce RA, Schwarzbauer JE, Doege K, Sandell LJ: Alternate exon usage is a commonly used mechanism for increasing coding diversity within genes coding for extracellular matrix proteins. Matrix 13:457, 1993
29. Faull RJ, Kovach NL, Harlan JM, Ginsberg MH: Affinity modulation of integrin α5β1: Regulation of the functional response by soluble fibronectin. J Cell Biol 121.155, 1993
30. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
31. Weiss RE, Reddi AH: Appearance of fibronectin during the differentiation of cartilage, bone, and bone marrow. J Cell Biol 88:630, 1981
32. Kleinman HK, Klebe RJ, Martin GR: Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 88:473, 1981
33. Simmons PJ, Masinovsky B, Longenecker BM, Derenson R, Torok-Storb B, Gallatin WM: Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80:388, 1992
34. Rogers SL, Letoumeau PC, Peterson BA, Furcht LT, McCarthy JB: Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin. J Cell Biol 105:1435, 1987
35. Cashman J, Eaves AC, Eaves CJ: Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood 66:1002, 1985
36. Rasey JS: In vitro assays for tumors grown in vivo, a review of kinetic techniques (chapter 4), in Gray JW, Darzynkiewicz Z (eds): Techniques in Cell Cycle Analysis. Clifton, NJ, Humana, p 79
37. Ormerod MG, Kubbies M: Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain. Cytometry 13:678, 1992
38. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL: Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122:897, 1993
39. Feichter G, Czech W, Haag D, Goerttler K, Futterman G, Loehrke H, Abel U: Comparison of S-phase fractions measured by flow cytometry and autoradiography in human transplant tumors. Cytometry 9:605, 1988
40. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96, 1990
41. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Landsdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
42. Eaves AC, Cashman JD, Wolpe SD, Eaves AC: Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci USA 90:12015, 1993
43. DeKlein A, Van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bostooma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelogenous leukemia. Nature 300:765, 1982
44. Tapley P, Horwitz A, Buck C, Duggan K, Rohrschneider L: Integrins isolated from Rous sarcoma virus-transformed chicken embryo fibroblasts. Oncogene 4:325, 1988
45. Horvath AR, Elmore MA, Kellie S: Differential tyrosine-specific phosphorylation of integrin in Rous sarcoma virus transformed cells with differing transformed phenotypes. Oncogene 5:1349, 1990
46. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH: Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 124:1047, 1994
47. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233, 1995
48. Salgia R, Li J-L, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, Sun Y, Pisick E, Hallek M, Ernst T, Tantravahi R, Chen LB, Griffin JD: Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210 BCR/ABL. J Biol Chem 270:5039, 1995
49. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML: BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175, 1993
50. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P: Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786, 1994
51. Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function Science 267:883, 1995
52. Faull RJ, Kovach NL, Harlan JM, Ginsberg MH: Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: Two mechanisms with divergent biological consequences. J Exp Med 179:1307, 1994
53. Bhatia R, McGlave PB, DeWald GW, Blazer BR, Verfaillie CM: Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: Role of malignant stromal macrophages. Blood 85:3636, 1995